
Vitamin D analog paricalcitol raised tumour response from 9% to 42% in pancreatic cancer
A shared news item on a 36-patient Dana-Farber trial where paricalcitol plus chemotherapy opened the protective barrier around metastatic pancreatic tumours. Small trial, so results are preliminary.

